Regeneron Pharmaceuticals (REGN) EBT (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly EBT of $1.5 billion for Q2 2026, up 0.6% year-over-year from $1.5 billion in Q2 2025, and up 83.81% quarter-over-quarter from $831.2 million in Q1 2026.
Regeneron Pharmaceuticals (REGN) EBT (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' EBT history runs 18 years deep, the most recent figure standing at $1.5 billion for Q2 2026.
- In Q2 2026, EBT rose 0.6% year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $5.2 billion (up 5.97% YoY), while the FY2025 annual figure was $5.2 billion, up 9.43% from the prior year.
- EBT for Q2 2026 stood at $1.5 billion, up from $831.2 million in the prior quarter.
- The five-year high for EBT was $1.8 billion in Q3 2025, with the low at $700.7 million in Q1 2024.
- The 5-year median for EBT is $1.1 billion (2023), against an average of $1.2 billion.
- The sharpest annual moves came in 2022 and 2024: EBT sank 74.33% in 2022, then jumped 50.35% in 2024.
- Regeneron Pharmaceuticals' EBT stood at $1.3 billion in 2022, then declined by 13.37% to $1.1 billion in 2023, then declined by 16.51% to $958.1 million in 2024, then rose by 8.93% to $1.0 billion in 2025, then soared by 46.38% to $1.5 billion in 2026.
- Business Quant data shows REGN's EBT at $1.5 billion in Q2 2026, $831.2 million in Q1 2026, and $1.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -294.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Bn |
| Mar 31, 2026 | 831.20 Mn |
| Dec 31, 2025 | 1.04 Bn |
| Sep 30, 2025 | 1.76 Bn |
| Jun 30, 2025 | 1.52 Bn |
| Mar 31, 2025 | 905.00 Mn |
| Dec 31, 2024 | 958.10 Mn |
| Sep 30, 2024 | 1.49 Bn |
| Jun 30, 2024 | 1.63 Bn |
| Mar 31, 2024 | 700.70 Mn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 858.00 Mn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.51 Bn |
| Jun 30, 2022 | 963.20 Mn |
| Mar 31, 2022 | 1.06 Bn |
| Dec 31, 2021 | 2.50 Bn |
| Sep 30, 2021 | 1.82 Bn |